These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Synthesis and biological activity of novel 3-(2-propenyl)-cephalosporins. I. Kim WJ; Ko KY; Kim H; Oh J J Antibiot (Tokyo); 1991 Oct; 44(10):1073-82. PubMed ID: 1955389 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of a new series of cephalosporins, BMY-28142 and related compounds. Naito T; Aburaki S; Kamachi H; Narita Y; Okumura J; Kawaguchi H J Antibiot (Tokyo); 1986 Aug; 39(8):1092-107. PubMed ID: 3759661 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug esters. Tomatsu K; Masuyoshi S; Hirano M; Kawaguchi H; Oki T; Fung-Tomc J; Desiderio JV; Kessler RE Antimicrob Agents Chemother; 1989 Apr; 33(4):489-97. PubMed ID: 2786371 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of a new series of cephalosporins having 3-substituted-ammonio-1-propenyl group as the C-3 side chain. Kamachi H; Oka M; Narita Y; Iimura S; Aburaki S; Yamashita H; Tomatsu K; Okumura J; Naito T J Antibiot (Tokyo); 1990 May; 43(5):533-43. PubMed ID: 2358405 [TBL] [Abstract][Full Text] [Related]
12. Orally active 7-phenylglycyl cephalosporins. Structure-activity studies related to cefatrizine (SK&F 60771). Dunn GL; Hoover JR; Berges DA; Taggart JJ; Davis LD; Dietz EM; Jakas DR; Yim N; Actor P; Uri JV; Weisbach JA J Antibiot (Tokyo); 1976 Jan; 29(1):65-80. PubMed ID: 776915 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2- aminothiazol-4-yl)-3-(substituted)-2-propenoylamino]-3-cephems with C-3 substitutions. Ishikura K; Kubota T; Minami K; Hamashima Y; Nakashimizu H; Motokawa K; Kimura Y; Miwa H; Yoshida T J Antibiot (Tokyo); 1994 Apr; 47(4):466-76. PubMed ID: 8195047 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin. Tomatsu K; Ando S; Masuyoshi S; Kondo S; Hirano M; Miyaki T; Kawaguchi H J Antibiot (Tokyo); 1987 Aug; 40(8):1175-83. PubMed ID: 3500158 [TBL] [Abstract][Full Text] [Related]
17. Cephalosporins having a heterocyclic catechol in the C3 side chain. II. Improvement of pharmacokinetic profile. Iimura S; Imae K; Hasegawa T; Okita T; Tamaoka M; Murata S; Kamachi H; Kamei H J Antibiot (Tokyo); 1993 May; 46(5):850-7. PubMed ID: 8514640 [TBL] [Abstract][Full Text] [Related]
18. Studies on orally active cephalosporins. II. Synthesis and structure-activity relations of new [(E) or (Z) 3-substituted carbamoyloxy]-1-propenyl cephalosporins. Negi S; Sasho M; Yamanaka M; Sugiyama I; Komatsu Y; Tsuruoka A; Kamada A; Tsukada I; Hiruma R; Katsu K J Antibiot (Tokyo); 1994 Dec; 47(12):1526-40. PubMed ID: 7844046 [TBL] [Abstract][Full Text] [Related]
19. Studies on cephalosporin antibiotics. VI. Synthesis, antibacterial activity and oral efficacy in mice of new 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)-acetamido]-3- (substituted alkylthio)cephalosporins. Yokoo C; Onodera A; Fukushima H; Numata K; Nagate T J Antibiot (Tokyo); 1992 Sep; 45(9):1533-9. PubMed ID: 1429240 [TBL] [Abstract][Full Text] [Related]